scispace - formally typeset
R

Rishi K Gupta

Researcher at University College London

Publications -  55
Citations -  2647

Rishi K Gupta is an academic researcher from University College London. The author has contributed to research in topics: Tuberculosis & Cohort. The author has an hindex of 17, co-authored 54 publications receiving 1299 citations. Previous affiliations of Rishi K Gupta include University of Cape Town & UCL Institute for Global Health.

Papers
More filters
Journal ArticleDOI

Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.

TL;DR: In resource-limited settings, TB accounts for approximately 40% of facility-based HIV/AIDS-related adult deaths and almost half of this disease remains undiagnosed at the time of death, highlighting the critical need to improve the prevention, diagnosis and treatment of HIV-associated TB globally.
Journal ArticleDOI

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

Clark D Russell, +355 more
TL;DR: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study as discussed by the authors is an ongoing, prospective cohort study recruiting inpatients from 260 hospitals in England, Scotland, and Wales, conducted by the ISARIC Coronavirus Clinical Characterization Consortium.
Journal ArticleDOI

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.

TL;DR: In this paper, a multivariable logistic regression model for in-hospital clinical deterioration (defined as any requirement of ventilatory support or critical care, or death) among consecutively hospitalised adults with highly suspected or confirmed COVID-19 who were prospectively recruited to the International Severe Acute Respiratory and Emerging Infections Consortium Coronavirus Clinical Characterisation Consortium (ISARIC4C) study across 260 hospitals in England, Scotland, and Wales.